A Randomized Clinical Trial of Feeder Vessel Photocoagulation of Proliferative Sickle Cell Retinopathy: I. Preliminary Results

L. M. Jampol*, P. Condon, M. Farber, M. Rabb, S. Ford, G. Serjeant

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

A randomized prospective clinical trial of feeder vessel photocoagulation for proliferative sickle cell retinopathy was performed. In Chicago there were 34 argon laser-treated eyes and 30 control eyes. In Kingston there were 53 xenon arc treated eyes and 50 control eyes. Prolonged loss of visual acuity was rare in both photocoagulated and control eyes. Argon laser and xenon arc feeder vessel photocoagulation reduced the incidence of vitreous hemorrhage and visual loss from vitreous hemorrhage. However, photocoagulation was associated with an increased risk of choroidal neovascularization (xenon arc greater than argon laser) and retinal detachment (argon laser), although visual loss from these complications has not been seen in these patients so far.

Original languageEnglish (US)
Pages (from-to)540-545
Number of pages6
JournalOphthalmology
Volume90
Issue number5
DOIs
StatePublished - Jan 1 1983

Keywords

  • argon laser
  • feeder vessel technique
  • photocoagulation
  • retinal detachment
  • sea fan
  • sickle cell retinopathy
  • vitreous hemorrhage
  • xenon arc

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'A Randomized Clinical Trial of Feeder Vessel Photocoagulation of Proliferative Sickle Cell Retinopathy: I. Preliminary Results'. Together they form a unique fingerprint.

Cite this